Intravascular Ultrasound (IVUS) Market Size, Share, Growth, and Industry Analysis, By Type (Platform Intravascular Ultrasound, Compact Intravascular Ultrasound), By Application (Peripheral Arterial Diseases, Cardiovascular Diseases), Regional Insights and Forecast to 2035
Intravascular Ultrasound (IVUS) Market Overview
The global Intravascular Ultrasound (IVUS) Market size is estimated at USD 765.66 million in 2026 and is projected to reach USD 1295.96 million by 2035, growing at a CAGR of 6.02% from 2026 to 2035.
The Intravascular Ultrasound (IVUS) Market is witnessing growing clinical acceptance as hospitals prioritize precision-guided cardiovascular interventions, improved stent deployment, and detailed vascular assessment. IVUS technology uses miniature ultrasound transducers mounted on catheters to generate real-time cross-sectional images of arterial structures, supporting accurate measurement of vessel dimensions, plaque characteristics, and stent expansion. The 2025 American cardiovascular guidelines established a Class I, Level A recommendation for intracoronary imaging during selected complex coronary interventions, strengthening the clinical rationale for advanced imaging adoption in 2026. IVUS typically provides approximately 100–150 micrometers of axial resolution, supporting visualization of vessel-wall structures that conventional angiography cannot adequately characterize. Increasing procedural complexity, peripheral vascular interventions, and integration with advanced catheterization platforms are important factors influencing equipment procurement and catheter utilization.
The United States remains a strategically important market for intravascular ultrasound technology because of its advanced interventional cardiology infrastructure, specialist training networks, and established procedural reimbursement mechanisms. In 2026, coronary intravascular imaging continues to be recognized through procedural codes 92978 and 92979, while peripheral IVUS procedures are represented by codes 37252 and 37253. These pathways support clinical adoption, although payment amounts and coverage requirements vary by setting and payer. American healthcare institutions increasingly evaluate IVUS for complex coronary lesions, stent optimization, and peripheral arterial procedures. The June 2026 introduction of clinical use of a dual-modality IVUS and optical imaging platform in the United States further demonstrates continuing innovation. Demand is particularly concentrated among hospitals performing complex percutaneous coronary interventions and multidisciplinary vascular procedures.
Key Findings
Latest Trends
The Intravascular Ultrasound (IVUS) Market is experiencing a significant transition toward multimodal imaging platforms that combine anatomical visualization, enhanced interpretation software, and integrated procedural guidance. In 2026, hybrid IVUS and optical imaging technology is increasingly attracting clinical interest because it combines deep vessel-wall assessment with detailed luminal visualization. Advanced systems offering 150-millimeter pullback capability can support evaluation across longer arterial segments. Artificial intelligence-assisted image interpretation, automated vessel measurements, and integrated catheterization-laboratory displays are becoming important product-development priorities. These technologies aim to reduce manual interpretation requirements and improve procedural consistency. Another important trend is the expansion of IVUS education and evidence-based procedural protocols. The 2026 introduction of an arterial IVUS educational application containing 3 disease-state modules, 40 clinical cases, and 40 image-interpretation guides highlights increasing attention to physician training. Meanwhile, recently published randomized studies are encouraging more selective examination of IVUS benefits across different patient groups.
Market Dynamics
Driver
Increasing demand for precise image-guided vascular interventions.
The primary driver of the Intravascular Ultrasound (IVUS) Market is the increasing clinical emphasis on accurate vascular visualization during complex coronary and peripheral interventions. Traditional angiography provides a two-dimensional representation of vascular anatomy but offers limited information about vessel-wall composition and stent expansion. IVUS provides approximately 100–150 micrometers of axial resolution and enables direct evaluation of vessel dimensions, calcification, and plaque distribution. Clinical guidance issued in 2025 strengthened the importance of intracoronary imaging by assigning Class I, Level A recommendations to selected complex coronary procedures. These recommendations encourage greater consideration of IVUS during treatment planning and procedural optimization. Growing attention to cardiovascular disease management also supports demand for advanced intravascular imaging. Complex lesions involving the left main coronary artery, bifurcations, and long arterial segments require detailed structural assessment that angiography alone may not provide. The IVUS-XPL clinical trial, involving 1,400 patients with long coronary lesions, reported major adverse cardiac event rates of 2.9% with IVUS guidance compared with 5.8% under angiographic guidance at 1 year.
Restraint
High acquisition costs and variable clinical benefits restrict broader adoption.
The relatively high cost of specialized imaging consoles, disposable ultrasound catheters, maintenance services, and operator training remains an important restraint on IVUS market expansion. Hospitals considering investment must evaluate procedural utilization, equipment compatibility, catheter consumption, and reimbursement eligibility. Facilities performing limited numbers of complex vascular interventions may find it difficult to justify dedicated platform acquisition. In the United States, 2026 reimbursement coding identifies separate coronary imaging services through codes 92978 and 92979, but reimbursement availability does not automatically guarantee favorable operating economics. Smaller hospitals and healthcare institutions with restricted equipment budgets therefore face greater barriers to widespread implementation. Clinical uncertainty concerning routine imaging also influences procurement decisions. At the 2026 American College of Cardiology scientific meeting, the IVUS-CHIP and OPTIMAL trials reported that IVUS-guided intervention was not superior to angiography-guided treatment for their respective primary clinical outcomes. IVUS-CHIP enrolled 2,020 patients with complex coronary disease, providing substantial additional evidence for procedure selection.
Opportunity
Hybrid imaging and peripheral interventions create additional growth opportunities.
Expansion of hybrid intravascular imaging represents an important opportunity for manufacturers developing differentiated cardiovascular technologies. Combining IVUS with optical imaging allows clinicians to evaluate vessel-wall structure and detailed luminal characteristics within a single diagnostic workflow. In June 2026, a dual-sensor imaging system entered reported clinical use in the United States with a 2.6 Fr catheter profile, compatibility with 6 Fr guiding catheters, and a 150-millimeter imaging pullback. These specifications demonstrate how manufacturers are improving procedural flexibility while reducing the need to exchange imaging devices. Continued advances in catheter miniaturization and automated interpretation could increase adoption among interventional cardiology specialists. Peripheral arterial interventions also provide opportunities for market diversification. IVUS can assist in evaluating vessel diameter, lesion length, and treatment outcomes in complex peripheral vascular anatomy. In 2026, separate United States procedural codes 37252 and 37253 continue to identify initial and additional peripheral vessels undergoing IVUS assessment. The development of dedicated educational resources covering peripheral arterial disease, vascular access, and abdominal aortic aneurysm procedures demonstrates expanding clinical interest.
Challenge
Operator training requirements and workflow integration remain significant challenges.
Achieving consistent clinical outcomes requires physicians to understand ultrasound image interpretation, plaque characteristics, vessel measurements, and stent optimization techniques. Intravascular imaging presents additional procedural steps compared with angiography alone, particularly when catheter preparation, pullback acquisition, and image analysis are not integrated efficiently. The 2026 development of an arterial IVUS educational platform containing 10 introductory modules and 40 clinical case studies illustrates the level of training support required for broader adoption. Hospitals must balance image quality and potential procedural improvements against staff availability, training resources, and catheterization-laboratory operating efficiency. Integration with existing imaging equipment presents another technical challenge. Hospitals may operate catheterization systems from multiple manufacturers, creating compatibility requirements involving displays, image storage, software interfaces, and procedural documentation. New platforms increasingly support combined imaging and physiology measurements, but implementing these capabilities across several operating rooms requires coordinated technical planning.
Segmentation Analysis
By Types
Platform Intravascular Ultrasound: Platform Intravascular Ultrasound systems represent the established product category for advanced interventional cardiology departments and high-volume catheterization laboratories. These configurations integrate ultrasound imaging consoles, visualization software, patient-interface modules, and catheter management capabilities into comprehensive procedural environments. They are particularly valuable when performing complex interventions requiring repeated measurements and detailed anatomical assessments. Contemporary systems may integrate imaging with coronary physiology capabilities, allowing clinicians to evaluate multiple diagnostic parameters during a single procedure.
Compact Intravascular Ultrasound: Compact Intravascular Ultrasound systems address demand for smaller equipment footprints, flexible catheterization-laboratory configurations, and simplified installation. These systems are particularly relevant for healthcare facilities seeking intravascular imaging capabilities without dedicating extensive space to traditional equipment. Compact configurations can improve accessibility in procedure rooms where multiple technologies must coexist, supporting efficient resource allocation. Some contemporary ultrasound imaging configurations support bed-rail or cart-mounted placement, enabling flexible operating arrangements. Development priorities increasingly include simplified controls, rapid image processing, and compatibility with established catheterization systems.
The competitive relationship between these 2 product categories is expected to evolve as manufacturers improve portability without compromising imaging performance. Hospitals performing complex cardiovascular procedures may continue favoring fully integrated platform systems, while smaller intervention centers may prefer compact configurations. Clinical requirements such as 150-millimeter imaging pullbacks, compatibility with standard guiding catheters, and automated vessel measurements increasingly influence purchasing decisions. Market-share allocation should therefore account for installed system numbers, procedure volumes, and disposable catheter consumption rather than treating all equipment configurations as commercially equivalent.
By Applications
Peripheral Arterial Diseases: Peripheral Arterial Diseases represent an increasingly important application area for IVUS technology as physicians seek accurate visualization during lower-extremity arterial interventions and other complex peripheral vascular procedures. IVUS enables assessment of arterial diameter, lesion length, plaque morphology, and treatment-related changes that may not be fully characterized through angiography alone. These capabilities support device sizing, procedural planning, and post-treatment evaluation. In the United States, procedural codes 37252 and 37253 recognize IVUS assessment involving an initial peripheral vessel and each additional vessel, respectively. Dedicated educational developments introduced in 2026 include peripheral arterial disease training modules and real-world interpretation cases.
Cardiovascular Diseases: Cardiovascular Diseases constitute the principal application category for IVUS technology, particularly during percutaneous coronary interventions involving complex coronary anatomy. Clinical applications include assessment of coronary plaque, vessel sizing, stent deployment, and identification of potential causes of stent failure. IVUS provides direct visualization of vessel-wall structures and enables measurements that conventional angiography cannot deliver with comparable anatomical detail. The 2025 Class I, Level A recommendation for intracoronary imaging in selected complex acute coronary syndrome procedures strengthened its clinical importance. Earlier randomized evidence involving 1,400 patients also demonstrated differences in major adverse cardiac event rates between IVUS-guided and angiography-guided coronary interventions.
Application-level demand is influenced by procedural complexity, physician expertise, hospital infrastructure, and reimbursement arrangements. Cardiovascular Diseases benefit from established imaging protocols and specialist training, whereas Peripheral Arterial Diseases offer opportunities for expansion into additional vascular treatment pathways. Both applications increasingly depend on advanced catheter technology capable of accurate measurements across different vessel sizes. As of 2026, the strongest evidence supports targeted IVUS use in complex cardiovascular procedures rather than universal deployment across every intervention. Consequently, application-specific growth through 2035 will depend on continued clinical validation, procedural standardization, and wider access to compatible imaging systems.
Regional Outlook
North America
North America is expected to maintain a prominent position in the Intravascular Ultrasound (IVUS) Market, supported by advanced hospital networks, specialized catheterization laboratories, and established interventional cardiology practices. The United States plays a central role in regional demand because healthcare providers have access to a wide range of IVUS systems, disposable catheters, and physician education programs. The 2025 Class I, Level A recommendation for intracoronary imaging in selected complex coronary interventions provides an important clinical basis for adoption. In 2026, coronary IVUS services continue to be identified through procedural codes 92978 and 92979, while peripheral IVUS services are represented by 37252 and 37253. These mechanisms facilitate standardized procedural identification, although actual reimbursement depends on coverage requirements. Hospitals are increasingly assessing IVUS capabilities alongside modern coronary physiology and imaging technologies. The regional market also benefits from ongoing manufacturer innovation and clinical technology introductions. In June 2026, the first reported United States procedure using a dual-sensor IVUS and optical imaging system demonstrated the commercialization of advanced hybrid imaging capabilities.
Europe
Europe represents an important market for intravascular ultrasound technology because of its established cardiovascular treatment infrastructure, clinical research networks, and emphasis on evidence-based intervention. The 2024 European recommendations assigned Class I, Level A status to intravascular imaging guidance for selected anatomically complex coronary interventions, including left main disease, true bifurcations, and long lesions. These recommendations provide a structured framework for hospitals evaluating IVUS deployment. Germany, France, Italy, Spain, and the United Kingdom are important healthcare markets with specialized cardiovascular treatment centers and experienced interventional cardiology teams. European institutions continue evaluating the role of IVUS in coronary stent optimization, vessel sizing, and complex lesion management. Adoption nevertheless varies because healthcare funding and reimbursement arrangements differ between individual countries. Clinical evidence generated in Europe is also influencing global IVUS utilization strategies. The 2026 IVUS-CHIP study enrolled 2,020 patients with complex coronary artery disease and reported that IVUS-guided intervention was not superior to angiography guidance for its primary outcome.
Asia-Pacific
Asia-Pacific presents substantial development opportunities for the Intravascular Ultrasound (IVUS) Market because of its large patient population, advanced cardiovascular centers, and expanding access to minimally invasive procedures. Japan is particularly important because intravascular imaging is already widely incorporated into coronary intervention practice. Japanese clinical evidence has documented imaging utilization rates of approximately 93% in one major coronary study and 94% in an observational registry, illustrating the potential for extensive adoption where specialist expertise and reimbursement support are established. China, India, South Korea, and Australia represent additional markets with varying levels of procedural capacity and equipment availability. Growth opportunities are particularly relevant in metropolitan healthcare networks and specialist cardiac hospitals introducing advanced catheter-based treatment. The regional market is also influenced by increasing demand for practical equipment configurations and enhanced physician education. Japan's established intravascular imaging ecosystem demonstrates how reimbursement, clinical guidelines, and technical familiarity can collectively influence adoption. Emerging Asia-Pacific healthcare systems may experience greater demand for Compact Intravascular Ultrasound equipment as hospitals expand catheterization services and seek efficient use of procedural space.
Middle East and Africa
The Middle East and Africa represent a developing IVUS market characterized by significant differences in healthcare infrastructure and specialist treatment availability. Gulf countries, including Saudi Arabia and the United Arab Emirates, are investing in advanced cardiovascular facilities and integrated catheterization technologies, creating favorable conditions for specialized intravascular imaging adoption. In September 2026, 2 hospitals in the United Arab Emirates introduced advanced artificial intelligence-supported catheterization facilities, demonstrating regional investment in sophisticated image-guided intervention infrastructure. Although such facilities do not independently establish IVUS installation volumes, they provide an important foundation for the broader adoption of advanced cardiovascular imaging. Demand remains concentrated in tertiary hospitals and specialized private healthcare institutions with sufficient procedural volumes. Across African healthcare systems, IVUS adoption is more restricted by equipment acquisition requirements, availability of specialized disposable catheters, and access to trained interventional cardiologists. Large referral hospitals in South Africa and selected North African countries represent the most likely centers for advanced procedural implementation.
Rest of the World
The Rest of the World category primarily includes Latin American markets and other healthcare systems not covered within the principal regional groupings. Brazil, Mexico, Argentina, and Chile represent important potential demand centers because of their established private hospitals, cardiovascular treatment facilities, and expanding minimally invasive intervention capabilities. Adoption is concentrated in specialist hospitals equipped to perform complex coronary procedures and support advanced image interpretation. IVUS offers approximately 100–150 micrometers of axial resolution, supporting more detailed assessment of vessel anatomy than conventional angiography alone. Nevertheless, equipment acquisition requirements, inconsistent procedural reimbursement, and limited specialist training can restrict implementation outside leading medical centers. Regional demand is therefore likely to develop unevenly across public and private healthcare networks. Opportunities for market expansion depend on improving access to integrated imaging systems, physician education, and dependable disposable catheter supplies. Compact IVUS equipment may be particularly attractive to hospitals seeking flexible installation without major changes to existing procedure rooms.
List of Top Intravascular Ultrasound (IVUS) Companies
Top 2 Companies with Highest Market Share
Investment Analysis and Opportunities
Investment activity in the Intravascular Ultrasound (IVUS) Market is increasingly focused on advanced imaging technologies, clinical validation, hybrid catheter development, and integration with catheterization-laboratory infrastructure. Companies developing combined IVUS and optical imaging technologies are attracting attention because multimodal platforms can expand diagnostic capabilities without requiring separate sequential catheter procedures. In January 2026, Conavi Medical completed a significant financing transaction to support its commercial and technological development activities. Such investments highlight continued interest in platforms offering differentiated vascular visualization. Manufacturers are also allocating resources toward automated image interpretation, physician education, and workflow optimization. The commercial attractiveness of these developments depends on demonstrable clinical utility, regulatory authorization, and sustainable adoption by specialist treatment centers. Emerging investment opportunities include compact imaging equipment, peripheral arterial applications, software-enabled anatomical measurements, and integration of ultrasound imaging with coronary physiology assessment. Product specifications such as 2.6 Fr catheter profiles and 150-millimeter pullback lengths illustrate the importance of procedural compatibility and technical performance.
New Product Development
New product development in the Intravascular Ultrasound (IVUS) Market increasingly emphasizes hybrid imaging, improved catheter deliverability, automated measurements, and simplified procedural integration. Modern systems are progressing beyond standalone ultrasound visualization toward platforms that combine complementary diagnostic technologies. In June 2026, a dual-sensor intravascular imaging system entered reported clinical use in the United States, combining IVUS with optical frequency domain imaging through a single catheter. Its technical specifications included a 2.6 Fr imaging profile, compatibility with 6 Fr guiding catheters, and a 150-millimeter imaging pullback. These characteristics demonstrate efforts to improve anatomical coverage while maintaining procedural flexibility. Manufacturers are also developing software that can facilitate more consistent image assessment and reduce repetitive manual measurements during complex interventions. Artificial intelligence and digital clinical education represent additional areas of product differentiation. Advanced software can assist clinicians in identifying vessel boundaries, measuring lumen dimensions, and evaluating stent deployment. However, automated measurements require appropriate validation and physician oversight before becoming routine decision-making tools.
Five Recent Developments
Future Outlook
The Intravascular Ultrasound (IVUS) Market is expected to evolve through 2035 as hospitals increasingly integrate anatomical imaging into selected cardiovascular and peripheral vascular interventions. Clinical adoption will remain influenced by evidence supporting precise vessel measurements, lesion characterization, and optimized stent deployment. The 2025 Class I, Level A recommendation for selected complex coronary interventions provides a favorable foundation for continued utilization. Nevertheless, findings from 2026 randomized trials involving complex coronary disease highlight the need to demonstrate benefits for specific patient populations. Manufacturers are therefore expected to emphasize reliable imaging performance, stronger clinical evidence, and efficient equipment integration rather than relying solely on expanding procedural volumes. Advanced platforms capable of supporting both imaging and physiological assessment may become increasingly important in specialist catheterization laboratories. Future technology development is likely to emphasize hybrid imaging, compact equipment configurations, artificial intelligence-assisted interpretation, and improved physician training. Imaging devices featuring 2.6 Fr catheter profiles and 150-millimeter pullback capabilities illustrate the continuing movement toward advanced, procedure-compatible technologies.
Intravascular Ultrasound (IVUS) Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 765.66 Million in 2026 |
|
|
Market Size Value By |
USD 1295.96 Million by 2035 |
|
|
Growth Rate |
CAGR of 6.02% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Intravascular Ultrasound (IVUS) Market is expected to reach USD 1295.96 Million by 2035.
The Intravascular Ultrasound (IVUS) Market is expected to exhibit a CAGR of 6.02% by 2035.
Boston Scientific, Terumo Medical, Philips, InfraReDx,Inc., VOLCANO, Medtronic, Siemens Healthcare, Bracco S.p.A., Conavi Medical Inc., Volcano Corporation
In 2026, the Intravascular Ultrasound (IVUS) Market is estimated at USD 765.66 Million.